DaVita Inc. (NYSE:DVA) Stock Holdings Increased by Financial Engines Advisors L.L.C.

Financial Engines Advisors L.L.C. lifted its position in DaVita Inc. (NYSE:DVA) by 2.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,112 shares of the company’s stock after acquiring an additional 403 shares during the quarter. Financial Engines Advisors L.L.C.’s holdings in DaVita were worth $2,260,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. MML Investors Services LLC grew its stake in shares of DaVita by 1.3% in the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after purchasing an additional 68 shares in the last quarter. Exchange Traded Concepts LLC grew its position in DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after buying an additional 68 shares in the last quarter. Impact Partnership Wealth LLC increased its stake in DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after buying an additional 70 shares during the period. Contravisory Investment Management Inc. raised its position in shares of DaVita by 1.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after buying an additional 73 shares in the last quarter. Finally, Nilsine Partners LLC lifted its stake in shares of DaVita by 0.8% in the 4th quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock worth $1,669,000 after acquiring an additional 92 shares during the period. 90.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on DVA. Barclays raised their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, StockNews.com lowered shares of DaVita from a “buy” rating to a “hold” rating in a research report on Friday, March 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $166.33.

DaVita Stock Performance

Shares of DVA opened at $151.30 on Thursday. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60. The company has a 50-day moving average of $157.96 and a two-hundred day moving average of $157.53. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market cap of $12.10 billion, a price-to-earnings ratio of 14.09, a PEG ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.